| Literature DB >> 30587148 |
Katja I Braam1,2, Elisabeth M van Dijk-Lokkart3, Gertjan J L Kaspers1,4, Tim Takken5, Jaap Huisman6,4, Laurien M Buffart7,8, Marc B Bierings9,4, Johannes H M Merks10,4, Marry M van den Heuvel-Eibrink11,4, Margreet A Veening1,4, Eline van Dulmen-den Broeder1.
Abstract
BACKGROUND: Physical fitness and psychosocial function is often reduced in children during or shortly after cancer treatment. This study evaluates the effect of a combined physical exercise and psychosocial intervention on cardiorespiratory fitness, muscle strength, body composition, psychosocial function and health-related quality of life (HrQoL). In addition, intervention mediators, applicability and adherence were examined.Entities:
Keywords: Cancer; Children; Intervention; Physical exercise; Psychosocial
Mesh:
Year: 2018 PMID: 30587148 PMCID: PMC6307314 DOI: 10.1186/s12885-018-5181-0
Source DB: PubMed Journal: BMC Cancer ISSN: 1471-2407 Impact factor: 4.430
Fig. 1Hypothesized physical and psychosocial mediators of the intervention effect on general HrQoL. Legend: HrQoL: health-related quality of life; M: mediation factors for HrQoL; N: Newton; VO2peak: peak oxygen uptake; ml.kg.min: milliliter per kilogram per minute; cpm: counts per minute
Fig. 2CONSORT diagram: flowchart of the study. Legend: n = number
Baseline characteristics of participants in the ‘Quality of Life in Motion (QLIM) study’
| Intervention group | Control group | |
|---|---|---|
| Age, mean (SD) years | 13.4 (3.1) | 13.1 (3.1) |
| Gender, male n (%) male | 16 (53%) | 21 (55%) |
| Height, mean (SD) cm | 158.9 (16.5) | 154.5 (17.2) |
| Weight, mean (SD) kg | 51.6(16.0) | 49.2 (16.9) |
| Cancer type, n (%) | ||
| ALL | 8 (27%) | 12 (32%) |
| AML, HL, non-HL, CML, Burkitt | 12 (40%) | 13 (34%) |
| CNS/brain tumor | 1 (3%) | 6 (16%) |
| Solid tumor | 9 (30%) | 7 (18%) |
| During treatment, n (%) | 9 (30%) | 12 (32%) |
| Lower body amputations | 2 (3%) | 2 (3%) |
| Upper body amputations | 2 (3%) | 1 (1%) |
Abbreviations: SD standard deviation, N number, ALL acute lymphoblastic leukemia, AML acute myeloid leukemia, HL Hodgkin lymphoma, non-H non-Hodgkin lymphoma, CML chronic myeloid leukemia, CNS central nervous system
*No significant differences at baseline between the two groups
Means and standard deviation scores per study outcome and measurement in the intervention and control group of the Quality of Life in Motion study
| Intervention ( | ( | ( | Control ( | ( | ( | |
|---|---|---|---|---|---|---|
| Pre | Post Short-term | Post Long-term | Pre | Post Short-term | Post Long-term | |
| mean (SD) | mean (SD) | mean (SD) | mean (SD) | mean (SD) | mean (SD) | |
| Primary outcomes | ||||||
| VO2peak, (ml.kg.min) | 30.1 (8.5) | 31.2 (9.5) | 33.8 (8.7) | 31.4 (9.5) | 33.0 (9.3) | 35.8 (8.4) |
| Upper body muscle strength (N) | 367.4 (114.0) | 363.1 (110.2) | 382.1 (95.8) | 370.2 (133.7) | 402.2 (148.7) | 416.0 (144.5) |
| Lower body muscle strength (N) | 587.7 (174.2) | 619.8 (197.5) | 660.5 (206.9) | 564.0 (206.6) | 595.5 (216.4) | 622.0 (219.2) |
| Secondary outcomes | ||||||
| Physical activity (cpm) | 153.4 (120.1) | 157.8 (81.7) | 213.1 (135.3) | 169.2 (97.4) | 156.5 (76.8) | 191.8 (110.1) |
| BMD lumbar spine (g/cm2) | 0.78 (0.21) | 0.78 (0.20) | 0.83 (0.23) | 0.75 (0.18) | 0.76 (0.20) | 0.78 (0.21) |
| % fat mass | 31.2 (8.5) | 30.1 (8.4) | 31.2 (8.6) | 31.0 (6.3) | 29.3 (6.9) | 29.2 (7.1) |
| General HrQoL | 68.4 (18.2) | 70.1 (15.7) | 77.2 (16.4) | 73.8 (14.1) | 73.8 (17.6) | 84.5 (13.1) |
| Fatigue | 67.7 (19.8) | 71.7 (17.9) | 76.5 (19.9) | 74.3 (15.7) | 76.7 (16.9) | 82.0 (17.3) |
| Extra outcomes used in mediation analysis | ||||||
| Depressive symptoms | 42.3 (31.3) | 43.2 (28.7) | 27.8 (29.4) | 40.1 (26.2) | 37.5 (27.2) | 28.2 (26.7) |
| Athletic competence | 40.1 (28.8) | 40.5 (25.4) | 51.9 (34.4) | 39.9 (31.9) | 39.8 (29.7) | 38.2 (29.9) |
| Global self-worth | 55.6 (29.6) | 60.0 (28.8) | 74.9 (25.9) | 57.3 (24.2) | 56.0 (29.3) | 63.4 (32.5) |
| Total problems | 45.7 (27.0) | 48.1 (29.1) | 37.5 (35.8) | 41.8 (29.2) | 39.3 (24.8) | 32.6 (27.3) |
Abbreviations: SD standard deviation, n number, VO2peak peak oxygen uptake, ml.kg.min− 1 millilitre per kilogram per minute, N Newton, counts per minute, cpm counts per minute, BMD bone mineral density, g/cm2 gram per square centimetre, % percentage, HrQoL health-related quality of life, * p < 0.05, %Corrected for baseline scores
Between-group differences and within-group changes over time on primary and secondary outcomes in participants of the Quality of Life in Motion study
| Between-group differences intervention group versus control group | Within group changes over time per study group | |||
|---|---|---|---|---|
| Short-term intervention effects % | Long-term intervention effects % | Intervention group ∞ | Control group ∞ | |
| β (95% CI) | β (95% CI) | β (95% CI) | β (95% CI) | |
| Primary outcomes | ||||
| VO2peak, (ml.kg.min−1) | −0.6 (−3.1; 2.0) | − 0.6 (− 3.6; 2.5) | 2.1 (− 0.4; 4.5) | 2.0 (− 0.04; 4.1) |
| Upper body muscle strength (N) | −20.4 (− 47.4; 6.5) | 4.5 (− 21.3; 30.3) | 36.8 (12.6; 60.9)* | 11.8 (−8.7; 32.4) |
| Lower body muscle strength (N) | 22.7 (− 19.8; 65.2) | 56.5 (8.5; 104.5)* | 49.1 (14.1; 84.0)* | 15.3 (−24.3; 54.9) |
| Secondary outcomes | ||||
| Physical activity (cpm) | 29.2 (−6.2; 64.8) | 8.2 (−44.3; 60.7) | 21.9 (−25.0; 68.9) | 42.9 (8.4; 77.5)* |
| BMD lumbar spine (g/cm2) | −0.001 (− 0.03; 0.02) | 0.007 (− 0.02; 0.03) | 0.04 (0.01; 0.07)** | 0.03 (0.02; 0.04)** |
| % fat mass | 0.6 (−0.7; 2.0) | 0.6 (−1.3; 2.5) | 0.6 (−0.5; 1.7) | 0.6 (− 0.4; 1.6) |
| General HrQoL | 1.6 (−5.0; 8.2) | −2.5 (−9.1; 4.1) | 5.6 (0.1; 11.0)* | 9.7 (4.6; 14.8)** |
| Fatigue | −1.6 (−7.5; 4.3) | − 1.8 (− 9.8; 6.2) | 3.7 (− 1.8; 9.3) | 4.0 (− 1.2;9.2) |
| Extra outcomes used in mediation analysis | ||||
| Depressive symptoms | 5.0 (−6.1; 16.1) | 1.1 (− 11.3; 13.5) | −1.1 (− 2.0; 1.6) | −1.3 (− 2.4; − 0.2)* |
| Athletic competence | −1.3 (− 10.7; 8.1) | 9.3 (− 4.4; 23.1) | 10.1 (− 4.8; 25.0) | −5.2 (− 13.7; 3.4) |
| Global self-worth | 0.04 (− 12.5; 12.6) | 0.8 (− 12.7; 14.3) | 7.5 (− 1.9; 16.8) | 4.6 (− 3.7; 12.8) |
| Total problems | 6.8 (− 4.8; 18.4) | 3.4 (− 12.1; 18.8) | −0.4 (− 5.0; 4.1) | − 0.5 (− 4.0; 3.1) |
Abbreviations: β: regression coefficient; CI: confidence interval; n of FU: number of follow-up measurements; VO2peak: peak oxygen uptake; ml.kg.min− 1: millilitre per kilogram per minute; N: Newton; counts per minute; cpm: counts per minute; BMD: bone mineral density; g/cm2: gram per square centimetre; %: percentage; HrQoL: health-related quality of life; * p < 0.05; %Corrected for baseline scores; ∞ Changes between baseline and long-term assessment
Direct and indirect intervention effects on general Health-related quality of life, intervention effects on potential mediators, effects of the mediators on general Health-related quality of life and the univariate mediation effects
| Intervention effect on the potential mediator | Association between the potential mediator and HrQoL | Intervention effect through the mediator on HrQoL | Mediation effect | ||
|---|---|---|---|---|---|
| (a path) | (b path) | (c’ path) | (a x b path) | ||
| β (95% CI) | β (95% CI) | β (95% CI) | estimate (95% CI) | n | |
| Potential mediators | |||||
| VO2peak (ml•kg•min− 1) | −0.5 (− 3.2; 2.1) | 0.3 (− 0.6; 1.1) | 0.3 (− 6.5; 7.1) | − 0.3 (− 3.3; 0.8) | 46 |
| Lower body muscle strength (N) | 22.7 (− 21.6;67.0) | − 0.0 (− 0.0; 0.0) | −3.3 (− 10.4; 3.8) | −0.1 (− 2.6; 0.7) | 50 |
| Upper body muscle strength (N) | −20.3 (− 48.6; 7.7) | 0.0 (− 0.0; 0.1) | −2.6 (− 9.7; 4.6) | −0.5 (− 3.9; 0.5) | 50 |
| Physical activity (cpm) | 29.1 (−9.8; 68.0) | −0.0 (− 0.1; 0.1) | 0.6 (− 9.4; 10.7) | −0.7 (− 8.5; 1.5) | 33 |
| Fatigue | −1.2 (− 7.6; 5.1) | 0.2 (− 0.1; 0.5) | −2.9 (− 10.1; 4.2) | −0.3 (− 3.7; 1.0) | 49 |
| Depressive symptoms | 0.2 (− 1.6; 2.0) | −1.4 (− 2.4; − 0.5)* | −3.5 (− 9.9; 3.0) | 0.7 (−2.4; 3.6) | 49 |
| Athletic competence | −1.5 (− 11.0; 8.1) | 0.2 (0.0; 0.4)* | −4.2 (− 11.3; 3.0) | 0.0 (− 2.8; 3.0) | 46 |
| Global self-worth | − 0.3 (− 13.2; 12.6) | 0.2 (0.0; 0.3)* | −5.2 (− 12.5; 2.2) | 1.0 (− 1.2; 4.8) | 46 |
| Behavior problems | 1.1 (−5.1; 7.2) | −0.5 (− 0.9; − 0.1)* | 0.6 (− 7.8; 8.9) | 0.3 (− 6.7; 3.6) | 30 |
Abbreviations: HrQoL: health-related quality of life; VO2peak: peak oxygen uptake; ml•kg•min− 1: milliliter per kilogram per minute; N: Newton; cpm: counts per minute; β: regression coefficient; CI: confidence interval; cpm: counts per minute; n: sample size per analyses; *p < 0.05